Enteroreceptors: The Gut's Sensory System – Types, Functions, and Clinical Relevance

What Are Enteroreceptors?

Enteroreceptors (gastrointestinal sensory receptors) are specialized nerve endings in the GI tract wall that detect mechanical, chemical, thermal, and noxious stimuli. They transduce luminal and mural signals into neural impulses transmitted via afferent fibers (vagal, splanchnic) to the CNS and enteric nervous system (ENS).

Classification by Modality

Type	Stimulus	Location	Key Functions
Mechanoreceptors	Stretch, tension, distension, contraction	Muscle layers, serosa	Volume sensing, peristaltic reflex, gastric accommodation, satiety signaling
Chemoreceptors	Nutrients, pH, osmolality, toxins, hormones	Mucosal epithelium, lamina propria	Digestive secretion (CCK, secretin, GIP), glucose sensing, nutrient absorption regulation, toxin detection
Thermoreceptors	Temperature changes	Mucosal/submucosal	Local blood flow regulation, thermogenesis coordination
Nociceptors	Tissue damage, ischemia, inflammation, excessive distension	All layers (esp. mucosa, serosa)	Visceral pain, protective reflexes (vomiting, diarrhea), autonomic responses

Additional Specialized Receptors

• OSA (Osmotic) receptors: Detect luminal osmolality → water secretion/absorption.
• Metaboreceptors: Sense metabolic byproducts (lactate, ATP) during ischemia/exercise.
• Enterochromaffin (EC) cells: Not neurons but sensory – release 5-HT (95% body's serotonin) in response to mechanical/chemical stimuli → activates intrinsic/extrinsic afferents.

Integrated Functions

1. Digestive control: Nutrient sensing → hormone release → enzyme/bile secretion, motility modulation.
2. Appetite regulation: Vagal afferents → NTS → hypothalamus (CCK, PYY, GLP-1, ghrelin).
3. Defense reflexes: Vomiting (chemoreceptor trigger zone + vagal), diarrhea (peristaltic rush), mucosal secretion.
4. Visceral hypersensitivity: In IBS, IBD, functional dyspepsia – enteroreceptors sensitized → pain at normal stimuli.
5. Gut-brain axis: Bidirectional communication via vagus, spinal afferents, humoral routes, microbiome metabolites.

Clinical Implications

• Visceral pain syndromes (IBS, functional chest pain) – peripheral and central sensitization.
• Gastroparesis – impaired mechanoreceptor feedback.
• Diabetic gastroenteropathy – autonomic neuropathy affecting enteroreceptor signaling.
• Drug targets: 5-HT₃ antagonists (ondansetron), 5-HT₄ agonists (prucalopride), TRPV1 antagonists, guanylate cyclase-C agonists (linaclotide).